Evidence map›Paper›PMID 16007133›Full record

ArticleOncogene2005

RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.

Ron Wisdom, Lyanne Huynh, Datsun Hsia, Sungeun Kim

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ron WisdomUC Davis Cancer Center and Division of Hematology and Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA. ronald.wisdom@ucdmc.ucdavis.edu
Lyanne Huynh
Datsun Hsia
Sungeun Kim
University of California, Davis · USUC Davis Comprehensive Cancer Center

Funding

MOLECULAR MECHANISMS OF TRANSFORMATION BY AP-1 PROTEINSR01CA064118 · NCI · VANDERBILT UNIVERSITY · PI WISDOM, RONALD M · 1995 to 2002
$777k
NCI NIH HHS CA64118
6 · The paper itself

Abstract

Ras, Raf, and Fos function as components in a signal transduction pathway that is constitutively active in many cancers. Many of the changes that underlie cell transformation arise through changes in gene expression. We have used gene expression profiling of 3T3 cells transformed by Ras, Raf, and Fos to define the common and distinct targets of transcriptional control by each of these oncogenes. In this analysis, the most strongly conserved feature of cell transformation at the transcriptional level is the transcriptional repression of genes that encode components of the extracellular matrix (ECM). TGF-beta treatment of fibroblasts is known to increase production of ECM, suggesting that TGF-beta might selectively reverse some of the gene expression changes that occur during cell transformation. Using gene expression profiling of the TGF-beta response, we show that the ability of TGF-beta to reverse the changes in gene expression brought about by cellular transformation is essentially confined to genes that encode components of the ECM and the cytoskeleton. This selective reversal of transformation-induced changes in gene expression is associated with partial reversal of many parameters of cell transformation. The results demonstrate a correlation between gene repression by the Ras/Raf/ERK signaling pathway, gene activation by the TGF-beta signaling pathway, and the transformed phenotype in fibroblasts.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAnimalsBlotting, NorthernBlotting, WesternCells, CulturedCell Transformation, NeoplasticExtracellular MatrixFibroblastsFluorescent Antibody TechniqueGenes, rasMiceOligonucleotide Array Sequence AnalysisProto-Oncogene Proteins c-rafRNA, MessengerSignal TransductionProto-Oncogene Proteins c-rafRNA, MessengerTransforming Growth Factor beta

Identifiers

PMID16007133
OpenAlexW2025547181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.